The DOI matches its Crossref record; 299 of the 299 references it cites were found in a registry or an index.
Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies
Abstract
Standard cancer therapies sometimes fail to deliver chemotherapeutic drugs to tumor cells in a safe and effective manner. Nanotechnology takes the lead in providing new therapeutic options for cancer due to major potential for selective targeting and controlled drug release. Antibodies and antibody fragments are attracting much attention as a source of targeting ligands to bind specific receptors that are overexpressed on cancer cells. Therefore, researchers are devoting time and effort to develop targeting strategies based on nanoparticles functionalized with antibodies, which hold great promise to enhance therapeutic efficacy and circumvent severe side effects. Several methods have been described to immobilize antibodies on the surface of nanoparticles. However, selecting the most appropriate for each application is challenging but also imperative to preserve antigen binding ability and yield stable antibody-conjugated nanoparticles. From this perspective, we aim to provide considerable knowledge on the most widely used methods of functionalization that can be helpful for decision-making and design of conjugation protocols as well. This review summarizes adsorption, covalent conjugation (carbodiimide, maleimide and "click" chemistries) and biotin-avidin interaction, while discussing the advantages, limitations and relevant therapeutic approaches currently under investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
Agard, N. J., Prescher, J. A., & Bertozzi, C. R. (2004) · Journal of the American Chemical Society · doi:10.1021/ja044996f · Cited by 3,017
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
IgG Subclasses and Allotypes: From Structure to Effector Functions
Vidarsson, G., Dekkers, G., & Rispens, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00520 · Cited by 2,667
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Cell Surface Engineering by a Modified Staudinger Reaction
Saxon, E., & Bertozzi, C. R. (2000) · Science · doi:10.1126/science.287.5460.2007 · Cited by 2,460
Strategies and challenges for the next generation of antibody–drug conjugates
Beck, A., Goetsch, L., Dumontet, C., & Corvaïa, N. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.268 · Cited by 2,271
Progress and challenges towards targeted delivery of cancer therapeutics
Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220
Hein, J. E., & Fokin, V. V. (2010) · Chemical Society Reviews · doi:10.1039/b904091a · Cited by 2,198
Fusion protein linkers: Property, design and functionality
Chen, X., Zaro, J. L., & Shen, W.-C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.039 · Cited by 2,056
Tumor delivery of macromolecular drugs based on the EPR effect
Torchilin, V. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.011 · Cited by 2,032
Structure and function of immunoglobulins
Schroeder, H. W., & Cavacini, L. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.09.046 · Cited by 1,905
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Wicki, A., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,901
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Copper-free click chemistry for dynamic in vivo imaging
Baskin, J. M., Prescher, J. A., Laughlin, S. T., Agard, N. J., Chang, P. V., Miller, I. A., Lo, A., Codelli, J. A., & Bertozzi, C. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707090104 · Cited by 1,833
Active targeting schemes for nanoparticle systems in cancer therapeutics
Byrne, J. D., Betancourt, T., & Brannon-Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,731
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles
Sperling, R. A., & Parak, W. J. (2010) · Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences · doi:10.1098/rsta.2009.0273 · Cited by 1,601
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,577
The generation of antibody-secreting plasma cells
Nutt, S. L., Hodgkin, P. D., Tarlinton, D. M., & Corcoran, L. M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3795 · Cited by 1,454
Therapeutic antibodies: successes, limitations and hopes for the future
Chames, P., Van Regenmortel, M., Weiss, E., & Baty, D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00190.x · Cited by 1,382
Danhier, F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.015 · Cited by 1,288
Inverse electron demand Diels–Alder reactions in chemical biology
Oliveira, B. L., Guo, Z., & Bernardes, G. J. L. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00184c · Cited by 1,139
(2013) · Elsevier eBooks · doi:10.1016/c2009-0-64240-9 · Cited by 1,139
Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
Nakamura, Y., Mochida, A., Choyke, P. L., & Kobayashi, H. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00437 · Cited by 1,101
The Role of Mechanical Forces in Tumor Growth and Therapy
Jain, R. K., Martin, J. D., & Stylianopoulos, T. (2014) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-105259 · Cited by 1,044
Endocytic mechanisms for targeted drug delivery☆
BAREFORD, L., & SWAAN, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.008 · Cited by 1,033
Nanomedicine(s) under the Microscope
Duncan, R., & Gaspar, R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 981
Selective chemical protein modification
Spicer, C. D., & Davis, B. G. (2014) · Nature Communications · doi:10.1038/ncomms5740 · Cited by 975
Ning, X., Guo, J., Wolfert, M. A., & Boons, G. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200705456 · Cited by 924
The making of bispecific antibodies
Brinkmann, U., & Kontermann, R. E. (2017) · mAbs · doi:10.1080/19420862.2016.1268307 · Cited by 923
Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy
Yu, M. K., Park, J., & Jon, S. (2012) · Theranostics · doi:10.7150/thno.3463 · Cited by 883
Nichols, J. W., & Bae, Y. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.057 · Cited by 834
Beyond binding: antibody effector functions in infectious diseases
Lu, L. L., Suscovich, T. J., Fortune, S. M., & Alter, G. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.106 · Cited by 825
Click Chemistry, A Powerful Tool for Pharmaceutical Sciences
Hein, C. D., Liu, X.-M., & Wang, D. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9616-1 · Cited by 813
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery
Sinha, R., Kim, G. J., Nie, S., & Shin, D. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0141 · Cited by 801
Nanoparticles for drug delivery in cancer treatment
Haley, B., & Frenkel, E. (2008) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.03.015 · Cited by 791
Click Chemistry in Complex Mixtures: Bioorthogonal Bioconjugation
McKay, C. S., & Finn, M. G. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.09.002 · Cited by 768
Cancer active targeting by nanoparticles: a comprehensive review of literature
Bazak, R., Houri, M., El Achy, S., Kamel, S., & Refaat, T. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1767-3 · Cited by 756
A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics
Steichen, S. D., Caldorera-Moore, M., & Peppas, N. A. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.12.006 · Cited by 751
Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems
Yoo, J., Park, C., Yi, G., Lee, D., & Koo, H. (2019) · Cancers · doi:10.3390/cancers11050640 · Cited by 726
Dommerholt, J., Schmidt, S., Temming, R., Hendriks, L. J. A., Rutjes, F. P. J. T., van Hest, J. C. M., Lefeber, D. J., Friedl, P., & van Delft, F. L. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201003761 · Cited by 720
Adams, G. P., Schier, R., McCall, A. M., Simmons, H. H., Horak, E. M., Alpaugh, R. K., Marks, J. D., & Weiner, L. M. (2001) · PubMed · Cited by 629
Agarwal, P., & Bertozzi, C. R. (2015) · Bioconjugate Chemistry · doi:10.1021/bc5004982 · Cited by 605
Copper-catalysed azide–alkyne cycloadditions (CuAAC): an update
Haldón, E., Nicasio, M. C., & Pérez, P. J. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob01457c · Cited by 598
Koniev, O., & Wagner, A. (2015) · Chem. Soc. Rev. · doi:10.1039/c5cs00048c · Cited by 594
The Binding Avidity of a Nanoparticle-Based Multivalent Targeted Drug Delivery Platform
Hong, S., Leroueil, P. R., Majoros, I. J., Orr, B. G., Baker, J. R., & Banaszak Holl, M. M. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.11.015 · Cited by 586
Aza-dibenzocyclooctynes for fast and efficient enzyme PEGylation via copper-free (3+2) cycloaddition
Debets, M. F., van Berkel, S. S., Schoffelen, S., Rutjes, F. P. J. T., van Hest, J. C. M., & van Delft, F. L. (2010) · Chem. Commun. · doi:10.1039/b917797c · Cited by 580
Stimuli‐responsive liposomes for drug delivery
Lee, Y., & Thompson, D. H. (2017) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1450 · Cited by 579
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles☆
WONG, H., BENDAYAN, R., RAUTH, A., LI, Y., & WU, X. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.008 · Cited by 578
Surface Functionalization of Exosomes Using Click Chemistry
Smyth, T., Petrova, K., Payton, N. M., Persaud, I., Redzic, J. S., Graner, M. W., Smith-Jones, P., & Anchordoquy, T. J. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500291r · Cited by 532
The structural basis of antibody–antigen recognition
Sela-Culang, I., Kunik, V., & Ofran, Y. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00302 · Cited by 530
Various methods of gold nanoparticles (GNPs) conjugation to antibodies
Jazayeri, M. H., Amani, H., Pourfatollah, A. A., Pazoki-Toroudi, H., & Sedighimoghaddam, B. (2016) · Sensing and Bio-Sensing Research · doi:10.1016/j.sbsr.2016.04.002 · Cited by 528
Particle shape enhances specificity of antibody-displaying nanoparticles
Barua, S., Yoo, J.-W., Kolhar, P., Wakankar, A., Gokarn, Y. R., & Mitragotri, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216893110 · Cited by 523
Biomedical Applications of Tetrazine Cycloadditions
Devaraj, N. K., & Weissleder, R. (2011) · Accounts of Chemical Research · doi:10.1021/ar200037t · Cited by 516
Nanoparticles and targeted drug delivery in cancer therapy
Bahrami, B., Hojjat-Farsangi, M., Mohammadi, H., Anvari, E., Ghalamfarsa, G., Yousefi, M., & Jadidi-Niaragh, F. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.07.015 · Cited by 510
Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review
Riaz, M., Riaz, M., Zhang, X., Lin, C., Wong, K., Chen, X., Zhang, G., Lu, A., & Yang, Z. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010195 · Cited by 509
Algar, W. R., Prasuhn, D. E., Stewart, M. H., Jennings, T. L., Blanco-Canosa, J. B., Dawson, P. E., & Medintz, I. L. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200065z · Cited by 502
Liu, H., & May, K. (2012) · mAbs · doi:10.4161/mabs.4.1.18347 · Cited by 484
Hoffman, W., Lakkis, F. G., & Chalasani, G. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09430915 · Cited by 482
Tunable Degradation of Maleimide–Thiol Adducts in Reducing Environments
Baldwin, A. D., & Kiick, K. L. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200148v · Cited by 470
Antibody orientation on biosensor surfaces: a minireview
Trilling, A. K., Beekwilder, J., & Zuilhof, H. (2013) · The Analyst · doi:10.1039/c2an36787d · Cited by 466
Jain, N., Smith, S. W., Ghone, S., & Tomczuk, B. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1657-7 · Cited by 459
Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody
Kocbek, P., Obermajer, N., Cegnar, M., Kos, J., & Kristl, J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.012 · Cited by 436
Molecular Interaction of Proteins and Peptides with Nanoparticles
Shemetov, A. A., Nabiev, I., & Sukhanova, A. (2012) · ACS Nano · doi:10.1021/nn300415x · Cited by 432
Conde, J., Dias, J. T., Grazú, V., Moros, M., Baptista, P. V., & de la Fuente, J. M. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00048 · Cited by 425
Biomedical applications of copper-free click chemistry: in vitro, in vivo, and ex vivo
Kim, E., & Koo, H. (2019) · Chemical Science · doi:10.1039/c9sc03368h · Cited by 421
Copper‐Catalyzed Azide–Alkyne Click Chemistry for Bioconjugation
Presolski, S. I., Hong, V. P., & Finn, M. G. (2011) · Current Protocols in Chemical Biology · doi:10.1002/9780470559277.ch110148 · Cited by 416
Recent development of biotin conjugation in biological imaging, sensing, and target delivery
Ren, W. X., Han, J., Uhm, S., Jang, Y. J., Kang, C., Kim, J.-H., & Kim, J. S. (2015) · Chemical Communications · doi:10.1039/c5cc03075g · Cited by 393
Multivalent Effects of RGD Peptides Obtained by Nanoparticle Display
Montet, X., Funovics, M., Montet-Abou, K., Weissleder, R., & Josephson, L. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060515m · Cited by 388
Quantification of thiols and disulfides
Winther, J. R., & Thorpe, C. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.03.031 · Cited by 385
Protein immobilization techniques for microfluidic assays
Kim, D., & Herr, A. E. (2013) · Biomicrofluidics · doi:10.1063/1.4816934 · Cited by 376
Strain-Promoted 1,3-Dipolar Cycloaddition of Cycloalkynes and Organic Azides
Dommerholt, J., Rutjes, F. P. J. T., & van Delft, F. L. (2016) · Topics in Current Chemistry · doi:10.1007/s41061-016-0016-4 · Cited by 376
Bioorthogonal chemistry: strategies and recent developments
Ramil, C. P., & Lin, Q. (2013) · Chemical Communications · doi:10.1039/c3cc44272a · Cited by 375
Tallawi, M., Rosellini, E., Barbani, N., Cascone, M. G., Rai, R., Saint-Pierre, G., & Boccaccini, A. R. (2015) · Journal of The Royal Society Interface · doi:10.1098/rsif.2015.0254 · Cited by 366
The Smart Targeting of Nanoparticles
Friedman, A., Claypool, S., & Liu, R. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990375 · Cited by 364
Odyssey of a cancer nanoparticle: From injection site to site of action
Nichols, J. W., & Bae, Y. H. (2012) · Nano Today · doi:10.1016/j.nantod.2012.10.010 · Cited by 364
Chen, S., Zhao, X., Chen, J., Chen, J., Kuznetsova, L., Wong, S. S., & Ojima, I. (2010) · Bioconjugate Chemistry · doi:10.1021/bc9005656 · Cited by 357
Recent advances in the construction of antibody–drug conjugates
Chudasama, V., Maruani, A., & Caddick, S. (2016) · Nature Chemistry · doi:10.1038/nchem.2415 · Cited by 352
Does a targeting ligand influence nanoparticle tumor localization or uptake?
Pirollo, K. F., & Chang, E. H. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.06.007 · Cited by 347
Nanoparticles as carriers for drug delivery in cancer
Dadwal, A., Baldi, A., & Kumar Narang, R. (2018) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.1080/21691401.2018.1457039 · Cited by 335
Surface Engineering of Liposomes for Stealth Behavior
Nag, O., & Awasthi, V. (2013) · Pharmaceutics · doi:10.3390/pharmaceutics5040542 · Cited by 322
Bioconjugation via azide–Staudinger ligation: an overview
Schilling, C. I., Jung, N., Biskup, M., Schepers, U., & Bräse, S. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00123f · Cited by 319
The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis
Jain, A., & Cheng, K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.016 · Cited by 304
Targeted nanodelivery of drugs and diagnostics
Phillips, M. A., Gran, M. L., & Peppas, N. A. (2010) · Nano Today · doi:10.1016/j.nantod.2010.03.003 · Cited by 297
Nanomedicine applied to translational oncology: A future perspective on cancer treatment
Bregoli, L., Movia, D., Gavigan-Imedio, J. D., Lysaght, J., Reynolds, J., & Prina-Mello, A. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.08.006 · Cited by 296
Antibody fragments as nanoparticle targeting ligands: a step in the right direction
Richards, D. A., Maruani, A., & Chudasama, V. (2017) · Chemical Science · doi:10.1039/c6sc02403c · Cited by 294
Rossin, R., van den Bosch, S. M., ten Hoeve, W., Carvelli, M., Versteegen, R. M., Lub, J., & Robillard, M. S. (2013) · Bioconjugate Chemistry · doi:10.1021/bc400153y · Cited by 291
Xenaki, K. T., Oliveira, S., & van Bergen en Henegouwen, P. M. P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01287 · Cited by 289
Irani, V., Guy, A. J., Andrew, D., Beeson, J. G., Ramsland, P. A., & Richards, J. S. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.03.255 · Cited by 288
Nanoparticle–blood interactions: the implications on solid tumour targeting
Lazarovits, J., Chen, Y. Y., Sykes, E. A., & Chan, W. C. W. (2015) · Chemical Communications · doi:10.1039/c4cc07644c · Cited by 285
Pickens, C. J., Johnson, S. N., Pressnall, M. M., Leon, M. A., & Berkland, C. J. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00633 · Cited by 285
Chances and pitfalls of chemical cross-linking with amine-reactive N-hydroxysuccinimide esters
Kalkhof, S., & Sinz, A. (2008) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-008-2231-5 · Cited by 282
Covalent Modification of Biomolecules through Maleimide-Based Labeling Strategies
Renault, K., Fredy, J. W., Renard, P.-Y., & Sabot, C. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00252 · Cited by 262
Thiol–ene Click Hydrogels for Therapeutic Delivery
Kharkar, P. M., Rehmann, M. S., Skeens, K. M., Maverakis, E., & Kloxin, A. M. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00420 · Cited by 258
Recent progress on nanoparticle-based drug delivery systems for cancer therapy
Xin, Y., Yin, M., Zhao, L., Meng, F., & Luo, L. (2017) · Cancer Biology & Medicine · doi:10.20892/j.issn.2095-3941.2017.0052 · Cited by 250
Konno, T., Maeda, H., Iwai, K., Maki, S., Tashiro, S., Uchida, M., & Miyauchi, Y. (1984) · Cancer · doi:10.1002/1097-0142(19841201)54:11<2367::aid-cncr2820541111>3.0.co;2-f · Cited by 233
Vauquelin, G., & Charlton, S. J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12106 · Cited by 231
Synthetic mimics of biotin/(strept)avidin
Liu, W., Samanta, S. K., Smith, B. D., & Isaacs, L. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00011a · Cited by 220
Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications
Dan, N., Setua, S., Kashyap, V., Khan, S., Jaggi, M., Yallapu, M., & Chauhan, S. (2018) · Pharmaceuticals · doi:10.3390/ph11020032 · Cited by 220
Shen, M., Rusling, J. F., & Dixit, C. K. (2017) · Methods · doi:10.1016/j.ymeth.2016.11.010 · Cited by 215
Protein Engineering For Directed Immobilization
Steen Redeker, E., Ta, D. T., Cortens, D., Billen, B., Guedens, W., & Adriaensens, P. (2013) · Bioconjugate Chemistry · doi:10.1021/bc4002823 · Cited by 214
Hu, C.-M. J., Kaushal, S., Cao, H. S. T., Aryal, S., Sartor, M., Esener, S., Bouvet, M., & Zhang, L. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900316a · Cited by 212
Highly Specific HER2-mediated Cellular Uptake of Antibody-modified Nanoparticles in Tumour Cells
Wartlick, H., Michaelis, K., Balthasar, S., Strebhardt, K., Kreuter, J., & Langer, K. (2004) · Journal of Drug Targeting · doi:10.1080/10611860400010697 · Cited by 211
Immunoliposomes: A review on functionalization strategies and targets for drug delivery
Eloy, J. O., Petrilli, R., Trevizan, L. N. F., & Chorilli, M. (2017) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2017.07.085 · Cited by 209
Controlled antibody/(bio-) conjugation of inorganic nanoparticles for targeted delivery
Montenegro, J.-M., Grazu, V., Sukhanova, A., Agarwal, S., de la Fuente, J. M., Nabiev, I., Greiner, A., & Parak, W. J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.12.003 · Cited by 207
Hollis, C. P., Weiss, H. L., Leggas, M., Evers, B. M., Gemeinhart, R. A., & Li, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.06.039 · Cited by 204
Dommerholt, J., van Rooijen, O., Borrmann, A., Guerra, C. F., Bickelhaupt, F. M., & van Delft, F. L. (2014) · Nature Communications · doi:10.1038/ncomms6378 · Cited by 203
Li, L., & Zhang, Z. (2016) · Molecules · doi:10.3390/molecules21101393 · Cited by 203
Avidin-biotin technology in targeted therapy
Lesch, H. P., Kaikkonen, M. U., Pikkarainen, J. T., & Ylä-Herttuala, S. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425241003677749 · Cited by 200
Egli, S., Nussbaumer, M. G., Balasubramanian, V., Chami, M., Bruns, N., Palivan, C., & Meier, W. (2011) · Journal of the American Chemical Society · doi:10.1021/ja110275f · Cited by 199
Feige, M. J., Hendershot, L. M., & Buchner, J. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.11.005 · Cited by 196
Binding to nanopatterned antigens is dominated by the spatial tolerance of antibodies
Shaw, A., Hoffecker, I. T., Smyrlaki, I., Rosa, J., Grevys, A., Bratlie, D., Sandlie, I., Michaelsen, T. E., Andersen, J. T., & Högberg, B. (2019) · Nature Nanotechnology · doi:10.1038/s41565-018-0336-3 · Cited by 196
Ligand-targeted theranostic nanomedicines against cancer
Yao, V. J., D'Angelo, S., Butler, K. S., Theron, C., Smith, T. L., Marchiò, S., Gelovani, J. G., Sidman, R. L., Dobroff, A. S., Brinker, C. J., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.002 · Cited by 195
Stéen, E. J. L., Edem, P. E., Nørregaard, K., Jørgensen, J. T., Shalgunov, V., Kjaer, A., & Herth, M. M. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.06.021 · Cited by 189
Bernardim, B., Cal, P. M. S. D., Matos, M. J., Oliveira, B. L., Martínez-Sáez, N., Albuquerque, I. S., Perkins, E., Corzana, F., Burtoloso, A. C. B., Jiménez-Osés, G., et al. (2016) · Nature Communications · doi:10.1038/ncomms13128 · Cited by 188
Hoffmann, R. M., Coumbe, B. G. T., Josephs, D. H., Mele, S., Ilieva, K. M., Cheung, A., Tutt, A. N., Spicer, J. F., Thurston, D. E., Crescioli, S., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1395127 · Cited by 188
Click Chemistry as a Tool for Cell Engineering and Drug Delivery
Takayama, Y., Kusamori, K., & Nishikawa, M. (2019) · Molecules · doi:10.3390/molecules24010172 · Cited by 187
Fcγ Receptor Function and the Design of Vaccination Strategies
Bournazos, S., & Ravetch, J. V. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.009 · Cited by 185
Martínez-Jothar, L., Doulkeridou, S., Schiffelers, R. M., Sastre Torano, J., Oliveira, S., van Nostrum, C. F., & Hennink, W. E. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.03.002 · Cited by 185
Antibody Engineering for Pursuing a Healthier Future
Saeed, A. F. U. H., Wang, R., Ling, S., & Wang, S. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00495 · Cited by 181
Targeted cancer therapy through antibody fragments-decorated nanomedicines
Alibakhshi, A., Abarghooi Kahaki, F., Ahangarzadeh, S., Yaghoobi, H., Yarian, F., Arezumand, R., Ranjbari, J., Mokhtarzadeh, A., & de la Guardia, M. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.10.036 · Cited by 181
Nanoparticle Functionalization and Its Potentials for Molecular Imaging
Thiruppathi, R., Mishra, S., Ganapathy, M., Padmanabhan, P., & Gulyás, B. (2017) · Advanced Science · doi:10.1002/advs.201600279 · Cited by 179
Schumacher, F. F., Nunes, J. P. M., Maruani, A., Chudasama, V., Smith, M. E. B., Chester, K. A., Baker, J. R., & Caddick, S. (2014) · Org. Biomol. Chem. · doi:10.1039/c4ob01550a · Cited by 175
Construction of homogeneous antibody–drug conjugates using site-selective protein chemistry
Akkapeddi, P., Azizi, S., Freedy, A. M., Cal, P. M. S. D., Góis, P. M. P., & Bernardes, G. J. L. (2016) · Chemical Science · doi:10.1039/c6sc00170j · Cited by 174
Zhang, J., Tang, H., Liu, Z., & Chen, B. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s148359 · Cited by 174
Stability of IgG isotypes in serum
Correia, I. (2010) · mAbs · doi:10.4161/mabs.2.3.11788 · Cited by 172
Peptide ligand-mediated targeted drug delivery of nanomedicines
Jiang, Z., Guan, J., Qian, J., & Zhan, C. (2019) · Biomaterials Science · doi:10.1039/c8bm01340c · Cited by 172
Methods for site-specific drug conjugation to antibodies
Behrens, C. R., & Liu, B. (2014) · mAbs · doi:10.4161/mabs.26632 · Cited by 171
Mechanisms of action of therapeutic antibodies for cancer
Redman, J. M., Hill, E. M., AlDeghaither, D., & Weiner, L. M. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.04.002 · Cited by 171
Monoclonal antibodies for the treatment of cancer
Shuptrine, C. W., Surana, R., & Weiner, L. M. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.009 · Cited by 170
A functional BCR in human IgA and IgM plasma cells
Pinto, D., Montani, E., Bolli, M., Garavaglia, G., Sallusto, F., Lanzavecchia, A., & Jarrossay, D. (2013) · Blood · doi:10.1182/blood-2012-09-459289 · Cited by 164
Vivek, R., Thangam, R., NipunBabu, V., Rejeeth, C., Sivasubramanian, S., Gunasekaran, P., Muthuchelian, K., & Kannan, S. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am406012g · Cited by 163
Wagner, S., Rothweiler, F., Anhorn, M. G., Sauer, D., Riemann, I., Weiss, E. C., Katsen‐Globa, A., Michaelis, M., Cinatl, J. J., Schwartz, D., et al. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.11.093 · Cited by 162
Brezski, R. J., & Jordan, R. E. (2010) · mAbs · doi:10.4161/mabs.2.3.11780 · Cited by 162
Puertas, S., Batalla, P., Moros, M., Polo, E., del Pino, P., Guisán, J. M., Grazú, V., & de la Fuente, J. M. (2011) · ACS Nano · doi:10.1021/nn200019s · Cited by 162
EGF Receptor-Targeted Nanocarriers for Enhanced Cancer Treatment
Master, А. M., & Gupta, A. S. (2012) · Nanomedicine · doi:10.2217/nnm.12.160 · Cited by 161
Application of click chemistry in nanoparticle modification and its targeted delivery
Yi, G., Son, J., Yoo, J., Park, C., & Koo, H. (2018) · Biomaterials Research · doi:10.1186/s40824-018-0123-0 · Cited by 160
Overview of Antibody Drug Delivery
Awwad, S., & Angkawinitwong, U. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030083 · Cited by 160
Investigation of stable and transient protein–protein interactions: Past, present, and future
Wetie, A. G. N., Sokolowska, I., Woods, A. G., Roy, U., Loo, J. A., & Darie, C. C. (2012) · PROTEOMICS · doi:10.1002/pmic.201200328 · Cited by 159
Liu, H., Chumsae, C. M., Gaza‐Bulseco, G., Hurkmans, K., & Radziejewski, C. H. (2010) · Analytical Chemistry · doi:10.1021/ac100575n · Cited by 154
Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery
Zhang, B., Hu, Y., & Pang, Z. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00952 · Cited by 152
de Oliveira, J. P., Prado, A. R., Keijok, W. J., Antunes, P. W. P., Yapuchura, E. R., & Guimarães, M. C. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-50424-5 · Cited by 148
Ig Constant Region Effects on Variable Region Structure and Function
Markmann, A. J., Bowen, A. D., Greenspan, N. S., & Casadevall, A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00022 · Cited by 145
The Growing Impact of Bioorthogonal Click Chemistry on the Development of Radiopharmaceuticals
Zeng, D., Zeglis, B. M., Lewis, J. S., & Anderson, C. J. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.115550 · Cited by 142
Targeted Therapeutic Nanoparticles: An Immense Promise to Fight against Cancer
Jahan, S. T., Sadat, S. M. A., Walliser, M., & Haddadi, A. (2017) · Journal of Drug Delivery · doi:10.1155/2017/9090325 · Cited by 140
Antibody-Conjugated Nanoparticles for Therapeutic Applications
Cardoso, M. M., Peça, I. N., & Roque, A. C. A. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800784667 · Cited by 139
Recent Advances in the Generation of Antibody–Nanomaterial Conjugates
Sivaram, A. J., Wardiana, A., Howard, C. B., Mahler, S. M., & Thurecht, K. J. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700607 · Cited by 139
Cysteines as Redox Molecular Switches and Targets of Disease
Fra, A., Yoboue, E. D., & Sitia, R. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00167 · Cited by 137
Chemical cross‐linking and native mass spectrometry: A fruitful combination for structural biology
Sinz, A., Arlt, C., Chorev, D. S., & Sharon, M. (2015) · Protein Science · doi:10.1002/pro.2696 · Cited by 136
Huang, H., Oizumi, S., Kojima, N., Niino, T., & Sakai, Y. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.05.004 · Cited by 134
Adumeau, P., Sharma, S. K., Brent, C., & Zeglis, B. M. (2016) · Molecular Imaging and Biology · doi:10.1007/s11307-015-0919-4 · Cited by 133
Antibody Fragments as Potential Biopharmaceuticals for Cancer Therapy: Success and Limitations
Kholodenko, R. V., Kalinovsky, D. V., Doronin, I. I., Ponomarev, E. D., & Kholodenko, I. V. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666170817152554 · Cited by 132
Liu, Y., Hou, W., Sun, H. R., Cui, C., Zhang, L., Jiang, Y. Y., Wu, Y., Wang, Y., Li, J., Sumerlin, B. S., et al. (2017) · Chemical Science · doi:10.1039/c7sc01447c · Cited by 130
Lu, R., Chang, Y., Chen, M., & Wu, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.12.061 · Cited by 129
Marco, M. D., Shamsuddin, S., Razak, K. A., Aziz, A. A., Devaux, C., Borghi, E., Levy, L., & Sadun, C. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s6458 · Cited by 129
Walsh, S. J., Omarjee, S., Galloway, W. R. J. D., Kwan, T. T.-L., Sore, H. F., Parker, J. S., Hyvönen, M., Carroll, J. S., & Spring, D. R. (2018) · Chemical Science · doi:10.1039/c8sc04645j · Cited by 128
Inorganic Complexes and Metal-Based Nanomaterials for Infectious Disease Diagnostics
Markwalter, C. F., Kantor, A. G., Moore, C. P., Richardson, K. A., & Wright, D. W. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00136 · Cited by 128
Zalba, S., Contreras-Sandoval, A. M., Haeri, A., ten Hagen, T. L. M., Navarro-Blasco, Í., Koning, G. A., & Garrido, M. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.05.271 · Cited by 127
Field Guide to Challenges and Opportunities in Antibody–Drug Conjugates for Chemists
Gordon, M. R., Canakci, M., Li, L., Zhuang, J., Osborne, B. A., & Thayumanavan, S. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00399 · Cited by 127
Site-Specific Antibody Conjugation for ADC and Beyond
Zhou, Q. (2017) · Biomedicines · doi:10.3390/biomedicines5040064 · Cited by 125
Lee, S. H., Park, O. K., Kim, J., Shin, K., Pack, C., Kim, K., Ko, G., Lee, N., Kwon, S., & Hyeon, T. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b04621 · Cited by 123
Altıntaş, I., Heukers, R., van der Meel, R., Lacombe, M., Amidi, M., Henegouwen, P. M. P. V. B. E., Hennink, W. E., Schiffelers, R. M., & Kok, R. J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.11.007 · Cited by 121
Characterization of covalent crosslinking strategies for synthesizing DNA-based bioconjugates
Wickramathilaka, M., & Tao, B. Y. (2019) · Journal of Biological Engineering · doi:10.1186/s13036-019-0191-2 · Cited by 121
Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy
Eloy, J. O., Petrilli, R., Chesca, D. L., Saggioro, F. P., Lee, R. J., & Marchetti, J. M. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.02.020 · Cited by 119
Lv, L., Liu, C., Chen, C., Yu, X., Chen, G., Shi, Y., Qin, F., Ou, J., Qiu, K., & Li, G. (2016) · Oncotarget · doi:10.18632/oncotarget.8607 · Cited by 118
Bioconjugation and stabilisation of biomolecules in biosensors
Liébana, S., & Drago, G. A. (2016) · Essays in Biochemistry · doi:10.1042/ebc20150007 · Cited by 117
Marco, M. D., Shamsuddin, S., Razak, K. A., Aziz, A. A., Devaux, C., Borghi, E., Lévy, L., & Sadun, C. (2010) · PubMed Central · Cited by 115
Trastuzumab decorated TPGS-g-chitosan nanoparticles for targeted breast cancer therapy
Mehata, A. K., Bharti, S., Singh, P., Viswanadh, M. K., Kumari, L., Agrawal, P., Singh, S. K., Koch, B., & Muthu, M. S. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.10.007 · Cited by 113
Sikorski, A. F., Toporkiewicz, M., Meissner, J. M., Matusewicz, L., & Czogalla, A. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s74514 · Cited by 112
McAuley, A., Jacob, J., Kolvenbach, C. G., Westland, K., Lee, H. J., Brych, S. R., Rehder, D. S., Kleemann, G. R., Brems, D. N., & Matsumura, M. (2007) · Protein Science · doi:10.1110/ps.073134408 · Cited by 110
Click Chemistry-Mediated Nanosensors for Biochemical Assays
Chen, Y., Xianyu, Y., Wu, J., Yin, B., & Jiang, X. (2016) · Theranostics · doi:10.7150/thno.14856 · Cited by 110
Greene, M. K., Richards, D. A., Nogueira, J. C. F., Campbell, K., Smyth, P., Fernández, M., Scott, C. J., & Chudasama, V. (2017) · Chemical Science · doi:10.1039/c7sc02747h · Cited by 109
Polonelli, L., Pontón, J., Elguezábal, N., Moragues, M. D., Casoli, C., Pilotti, E., Ronzi, P., Dobroff, A. S., Rodrigues, E. G., Juliano, M. A., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002371 · Cited by 107
Carbodiimide Induced Cross-Linking, Ligand Addition, and Degradation in Gelatin
Cammarata, C. R., Hughes, M. E., & Ofner, C. M. (2015) · Molecular Pharmaceutics · doi:10.1021/mp5006118 · Cited by 107
Dondelinger, M., Filée, P., Sauvage, E., Quinting, B., Muyldermans, S., Galleni, M., & Vandevenne, M. S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02278 · Cited by 107
Xu, S., Cui, F., Huang, D., Zhang, D., Zhu, A., Sun, X., Cao, Y., Ding, S., Wang, Y., Gao, E., et al. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s175340 · Cited by 106
Therapeutic Antibodies Against Cancer
Adler, M. J., & Dimitrov, D. S. (2012) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2012.02.013 · Cited by 103
Site‐Selective Disulfide Modification of Proteins: Expanding Diversity beyond the Proteome
Kuan, S. L., Wang, T., & Weil, T. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201602298 · Cited by 102
Lin, C., Wong, B. C. K., Chen, H., Bian, Z., Zhang, G., Zhang, X., Riaz, M. K., Tyagi, D., Lin, G., Zhang, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00957-4 · Cited by 101
Cisplatin-loaded PLGA nanoparticles for HER2 targeted ovarian cancer therapy
Domínguez-Ríos, R., Sánchez-Ramírez, D. R., Ruiz-Saray, K., Oceguera-Basurto, P. E., Almada, M., Juárez, J., Zepeda‐Moreno, A., Toro‐Arreola, A. D., Topete, A., & Daneri‐Navarro, A. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.03.011 · Cited by 101
Assessment of disulfide and hinge modifications in monoclonal antibodies
Moritz, B., & Stracke, J. O. (2016) · Electrophoresis · doi:10.1002/elps.201600425 · Cited by 99
Schnyder, A., Krähenbühl, S., Drewe, J., & Huwyler, J. (2005) · Journal of drug targeting · doi:10.1080/10611860500206674 · Cited by 95
Sabra, R., Billa, N., & Roberts, C. J. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118775 · Cited by 93
Gloria, K., & Nie, S. (2005) · Materials Today · doi:10.1016/s1369-7021(05)71034-8 · Cited by 92
Low Modulus Biomimetic Microgel Particles with High Loading of Hemoglobin
Chen, K., Merkel, T. J., Pandya, A., Napier, M. E., Luft, J. C., Daniel, W., Sheiko, S. S., & DeSimone, J. M. (2012) · Biomacromolecules · doi:10.1021/bm3007242 · Cited by 91
Poly(Sarcosine) Surface Modification Imparts Stealth‐Like Properties to Liposomes
Bleher, S., Buck, J., Muhl, C., Sieber, S., Barnert, S., Witzigmann, D., Huwyler, J., Barz, M., & Süss, R. (2019) · Small · doi:10.1002/smll.201904716 · Cited by 91
Organic nanoscale drug carriers coupled with ligands for targeted drug delivery in cancer
Shi, M., Lu, J., & Shoichet, M. S. (2009) · Journal of Materials Chemistry · doi:10.1039/b822319j · Cited by 90
Guo, S., Zhang, Y., Wu, Z., Zhang, L., He, D., Li, X., & Wang, Z. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109225 · Cited by 89
Roncato, F., Rruga, F., Porcù, E., Casarin, E., Ronca, R., Maccarinelli, F., Realdon, N., Basso, G., Alon, R., Viola, G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06602-6 · Cited by 86
Yang, C., Gao, X., & Gong, R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01860 · Cited by 85
Antigen binding allosterically promotes Fc receptor recognition
Zhao, J., Nussinov, R., & Ma, B. (2018) · mAbs · doi:10.1080/19420862.2018.1522178 · Cited by 85
Comparison of Avidin, Neutravidin, and Streptavidin as Nanocarriers for Efficient siRNA Delivery
Jain, A., Barve, A. J., Zhao, Z., Jin, W., & Cheng, K. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00933 · Cited by 83
Cited by
Nanomedicine in cancer therapy
Fan, D., Cao, Y., Cao, M., Wang, Y., Cao, Y., & Gong, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01536-y · Cited by 878
Nanoparticles in Clinical Translation for Cancer Therapy
Mundekkad, D., & Cho, W. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031685 · Cited by 305
Billingsley, M. M., Gong, N., Mukalel, A. J., Thatte, A. S., El‐Mayta, R., Patel, S. K., Metzloff, A. E., Swingle, K. L., Han, X., Xue, L., et al. (2024) · Small · doi:10.1002/smll.202304378 · Cited by 268
Advancing engineering design strategies for targeted cancer nanomedicine
Gomerdinger, V. F., Nabar, N., & Hammond, P. T. (2025) · Nature Reviews Cancer · doi:10.1038/s41568-025-00847-2 · Cited by 146
The impact of protein corona on the biological behavior of targeting nanomedicines
Farshbaf, M., Valizadeh, H., Panahi, Y., Fatahi, Y., Chen, M., Zarebkohan, A., & Gao, H. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121458 · Cited by 95
Metadata
- Authors
- Marques, A. C., Costa, P. J., Velho, S., & Amaral, M. H.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 320
- Pages
- 180-200
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W3001632525
- Cited by
- 349
- References
- 299
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.